Lmr Partners LLP Gossamer Bio, Inc. Transaction History

Lmr Partners LLP

$8.3 Billion
Q1 2025

A detailed history of Lmr Partners LLP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 115,649 shares of GOSS stock, worth $145,717. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115,649

Holding current value

$145,717

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 15, 2025	BUY	$0.85 - $1.53 $98,301 - $176,942	115,649 New	115,649 $127,000
Q1 2024 May 15, 2024	BUY	$0.8 - $1.51 $46,756 - $88,251	58,445 New	58,445 $68,000

Others Institutions Holding GOSS

# of Institutions

127

Shares Held

162M

Call Options Held

2.11M

Put Options Held

57.8K

Octagon Capital Advisors LP New York, NY

18.4M
Shares

$23.1 Million
6.72% of portfolio
Nea Management Company, LLC Timonium, MD

18.1M
Shares

$22.8 Million
1.89% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$12.7 Million
0.0% of portfolio
Arch Venture Management, LLC Chicago, IL

8.06M
Shares

$10.2 Million
7.27% of portfolio
Acadian Asset Management LLC Boston, MA

6.36M
Shares

$8.01 Million
0.02% of portfolio

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $118M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account